Postmarketing safety analysis of upadacitinib in atopic dermatitis: A Food and Drug Administration adverse reporting system review of boxed warning-related adverse events.

Publication Title

Journal of the American Academy of Dermatology

Authors

Aditya Joshi
Lauren Gawey
Muhammad Rahman
Raveena Ghanshani
Khiem A Tran, Swedish Health Services, Seattle, Washington USAFollow
Jennifer L Hsiao
Vivian Y Shi

Document Type

Article

Publication Date

8-1-2025

Keywords

washington; swedish

Specialty/Research Institute

Dermatology

DOI

10.1016/j.jaad.2025.04.046